• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS ESHEATH INTRODUCER SET; INTRODUCER, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS ESHEATH INTRODUCER SET; INTRODUCER, CATHETER Back to Search Results
Model Number 9610ES16
Device Problem Material Integrity Problem (2978)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 04/22/2022
Event Type  Injury  
Manufacturer Narrative
The investigation is ongoing.A supplemental report will be completed upon completion.This is one of two manufacturer reports being submitted for this case.Please reference related manufacturer report no: 2015691-2022-05734.
 
Event Description
Edwards received notification from our affiliate (b)(6).As reported, this was a case of an implant of 29mm edwards sapien 3 transcatheter heart valve, in the aortic position by transfemoral approach.During the procedure, following balloon deflation, 7 ml of fluid was left in the balloon.The fluid caused the balloon to parachute, which led to difficulty withdrawing the balloon into the esheath and caused a dissection of the iliac artery.The sheath and delivery system were pulled out of the body as one unit.Per images provided, the esheath liner was observed to be delaminated.
 
Manufacturer Narrative
The device was not returned for evaluation as it was discarded.Therefore, a no product return engineering evaluation was performed.Imagery was provided from the site and the following was observed: the sheath liner was delaminated and bunched at the distal end.The balloon was bunched over the nose cone and exposed through the bunched liner.The sheath appeared curved from use.Procedural cine was returned and showed the delivery system not being fully deflated prior to the removal from deployed thv.The device history record (dhr) review did not reveal any manufacturing nonconformance issues that would have contributed to the event.A lot history review was performed and revealed no other complaints relating to this event.A review of edwards lifesciences risk management documentation was performed for this case.The reported event is an anticipated risk of the transcatheter heart valve procedure, additional assessment of the failure mode is not required at this time.The complaints sheath liner delamination was confirmed by the provided procedural imagery.Due to the unavailability of the device, engineering was unable to perform any visual, functional, or dimensional analysis.Therefore, a manufacturing non-conformance could not be determined.However, review of the device history record, lot history, and complaint history did not provide any indication that manufacturing non- conformance would have contributed to the complaint.A review of ifu/training materials revealed no deficiencies.As there was no note of abnormalities during device preparation, it is unlikely that the reported event was an issue out of box.The complaint stated, ''the inability to deflate'' caused the balloon to parachute, causing sheath to split''.Per training manual, delivery system must be fully deflated prior to removal.As the delivery system was unable to complete deflate, residual fluid left inside the balloon can increase the balloon profile and result in difficulties withdrawing the balloon and esheath delamination, as seen in returned imagery.The access vessel was also noted to be mildly tortuous which can influence the angle of retrieval of the delivery system through the sheath.This coupled with the altered balloon profile likely resulted in the delamination.While a definitive root cause is unknown, it is possible that patient (tortuosity) and procedural factors (excessive manipulation, withdrawal of altered balloon profile, residual fluid) contributed to the complaint event.No labeling or ifu inadequacies have been identified.Since no edwards defect was identified, no corrective or preventative action is required.Complaint histories for all reported events are reviewed against trending control limits monthly, and any excursions above the control limits are assessed and documented as part of this monthly review.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS ESHEATH INTRODUCER SET
Type of Device
INTRODUCER, CATHETER
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
renee van dorne
1 edwards way
irvine, CA 92614
9492506385
MDR Report Key14431969
MDR Text Key293502737
Report Number2015691-2022-05748
Device Sequence Number1
Product Code DYB
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K200258
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/24/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/05/2022
Device Model Number9610ES16
Device Catalogue NumberN/A
Device Lot Number63505964
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 04/22/2022
Initial Date FDA Received05/18/2022
Supplement Dates Manufacturer Received06/23/2022
Supplement Dates FDA Received06/23/2022
Was Device Evaluated by Manufacturer? No
Date Device Manufactured11/05/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age84 YR
Patient SexMale
-
-